Published in J Allergy Clin Immunol on December 24, 2014
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J (2015) 1.03
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol (2014) 0.97
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy. J Allergy Clin Immunol (2015) 0.90
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol (2016) 0.80
The rise of food allergy: Environmental factors and emerging treatments. EBioMedicine (2016) 0.79
Current Options for the Treatment of Food Allergy. Pediatr Clin North Am (2015) 0.77
Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness. Allergy (2016) 0.77
Mechanistic Correlates of Clinical Responses to Omalizumab in the Setting of Oral Immunotherapy for Milk Allergy. J Allergy Clin Immunol (2017) 0.76
Innate and adaptive dendritic cell responses to immunotherapy. Curr Opin Allergy Clin Immunol (2015) 0.75
Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2. J Allergy Clin Immunol (2016) 0.75
Desensitization for Peanut Allergies in Children. Curr Treat Options Allergy (2016) 0.75
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy. J Allergy Clin Immunol (2016) 0.75
Recent advances in immunotherapy and vaccine development for peanut allergy. Ther Adv Vaccines (2015) 0.75
B-FAHF-2 plus oral immunotherapy (OIT) is safer and more effective than OIT alone in a murine model of concurrent peanut/tree nut allergy. Clin Exp Allergy (2017) 0.75
Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol (2001) 5.80
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Oral immunotherapy for treatment of egg allergy in children. N Engl J Med (2012) 5.19
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science (2011) 4.96
US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol (2010) 3.99
Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol (2009) 3.91
Basophils enhance immunological memory responses. Nat Immunol (2008) 3.35
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol (2011) 2.77
Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol (2010) 2.50
Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med (1989) 2.34
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol (2011) 1.93
The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol (2011) 1.81
The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol (2006) 1.79
CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol (2004) 1.56
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol (2014) 1.49
Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin Exp Allergy (2010) 1.35
Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion. J Allergy Clin Immunol (2005) 1.25
Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow's milk tolerance. J Allergy Clin Immunol (2012) 1.24
Evaluation of basophil activation in food allergy: present and future applications. Curr Opin Allergy Clin Immunol (2006) 1.23
Human basophils: mediator release and cytokine production. Adv Immunol (2001) 1.20
Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. J Allergy Clin Immunol (2004) 1.11
Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy (2012) 1.08
Immunology in the Clinic Review Series; focus on allergies: immunotherapy for food allergy. Clin Exp Immunol (2012) 0.98
Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol (2013) 0.97
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol (2014) 0.97
The role of dendritic cells in food allergy. J Allergy Clin Immunol (2012) 0.95
Dendritic cell and T cell responses in children with food allergy. Clin Exp Allergy (2010) 0.91
Innate immunostimulatory properties of allergens and their relevance to food allergy. Semin Immunopathol (2012) 0.89
Impact of immunotherapy on blood dendritic cells in patients with Hymenoptera venom allergy. J Allergy Clin Immunol (2011) 0.87
Spontaneous basophil responses in food-allergic children are transferable by plasma and are IgE-dependent. J Allergy Clin Immunol (2013) 0.82
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol (2014) 0.97
Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol (2014) 0.96